help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 12, 2006
Molecular Endocrinology, doi:10.1210/me.2006-0072
A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
21/1/30    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Folkertsma, S.
Right arrow Articles by de Vlieg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Folkertsma, S.
Right arrow Articles by de Vlieg, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Submitted on February 10, 2006
Accepted on October 6, 2006

The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the RXR{alpha} ligand-binding domain

Simon Folkertsma, Paula I. van Noort, Arnold de Heer, Peter Carati, Ralph Brandt, Arie Visser, Gerrit Vriend, and Jacob de Vlieg*

Centre for Molecular and Biomolecular Informatics (CMBI), University of Nijmegen, PO Box 9010, 6500 GL, Nijmegen, the Netherlands; Organon NV, PO Box 20, 5340 BH, Oss, the Netherlands

* To whom correspondence should be addressed. E-mail: jacob.devlieg{at}organon.com.

It is hypothesized that different ligand-induced conformational changes can explain the different interactions of nuclear receptors with regulatory proteins, resulting in specific biological activities. Understanding the mechanism of how ligands regulate cofactor interaction facilitates drug design. To investigate these ligand-induced conformational changes at the surface of proteins we performed a time-resolved fluorescence resonance energy transfer assay with 52 different cofactor peptides measuring the ligand-induced cofactor recruitment to the retinoid X receptor alpha in the presence of eleven compounds. Simultaneously we analyzed the binding modes of these compounds by molecular docking. An automated method converted the complex 3D data of ligand-protein interactions into 2D fingerprints, the so-called ligand-receptor interaction profiles.

For a subset of compounds the conformational changes at the surface as measured by peptide recruitment correlate well with the calculated binding modes, suggesting that clustering of ligand-receptor interaction profiles is a very useful tool to discriminate compounds that may induce different conformations and possibly different effects in a cellular environment. In addition, we successfully combined ligand-receptor interaction profiles and peptide recruitment data to reveal structural elements that are possibly involved in the ligand-induced conformations. Interestingly, we could predict a possible binding mode of LG100754, a homodimer antagonist that showed no effect on peptide recruitment. Finally, the extensive analysis of the peptide recruitment profiles provided novel insight in the potential cellular effect of the compound; for the first time, we showed that besides the induction of coactivator peptide binding, all well-known RXR{alpha}"agonists" also induce binding of corepressor peptides to RXR{alpha}.


Key words: Nuclear receptors • ligand-binding residues • conformational changes • compound profiling • peptide recruitment

NURSA Molecule Pages Link:

Nuclear Receptors:   DAX1  |  SHP  |  LXRα  |  RXRα
Coregulators:   RIP140  |  TRAP220  |  PGC-1  |  LCoR  |  CBP  |  FHL2  |  SRC-1  |  GRIP1  |  AIB1  |  ARA70  |  ASC-2  |  NCOR  |  SMRT
Ligands:   LGD 100268  |  9-cis-Retinoic acid  |  Arotinoid acid






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society